On Tuesday, Tarsus Pharmaceuticals Inc (NASDAQ: TARS) opened higher 3.78% from the last session, before settling in for the closing price of $74.17. Price fluctuations for TARS have ranged from $38.51 to $76.81 over the past 52 weeks.
A company in the Healthcare sector has dropped its sales by -66.60% annually for the last half of the decade. Company’s average yearly earnings per share was noted 51.83% at the time writing. With a float of $38.82 million, this company’s outstanding shares have now reached $42.45 million.
Tarsus Pharmaceuticals Inc (TARS) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tarsus Pharmaceuticals Inc is 8.55%, while institutional ownership is 104.79%. The most recent insider transaction that took place on Sep 24 ’25, was worth 332,220. In this transaction President/CEO and Board Chair of this company sold 6,000 shares at a rate of $55.37, taking the stock ownership to the 812,106 shares. Before that another transaction happened on Sep 24 ’25, when Company’s Officer proposed sale 6,000 for $55.37, making the entire transaction worth $332,208.
Tarsus Pharmaceuticals Inc (TARS) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.6 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.78) by 0.18. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.83% per share during the next fiscal year.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Trading Performance Indicators
Check out the current performance indicators for Tarsus Pharmaceuticals Inc (TARS). In the past quarter, the stock posted a quick ratio of 4.25. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.92.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.59 in one year’s time.
Technical Analysis of Tarsus Pharmaceuticals Inc (TARS)
Let’s dig in a bit further. During the last 5-days, its volume was 0.39 million. That was inferior than the volume of 0.65 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 77.29%.
During the past 100 days, Tarsus Pharmaceuticals Inc’s (TARS) raw stochastic average was set at 95.55%, which indicates a significant increase from 86.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.37 in the past 14 days, which was higher than the 2.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $65.09, while its 200-day Moving Average is $51.40. However, in the short run, Tarsus Pharmaceuticals Inc’s stock first resistance to watch stands at $79.45. Second resistance stands at $81.94. The third major resistance level sits at $85.11. If the price goes on to break the first support level at $73.79, it is likely to go to the next support level at $70.62. Assuming the price breaks the second support level, the third support level stands at $68.13.
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) Key Stats
There are currently 42,449K shares outstanding in the company with a market cap of 3.27 billion. Presently, the company’s annual sales total 182,950 K according to its annual income of -115,550 K. Last quarter, the company’s sales amounted to 118,700 K and its income totaled -12,590 K.
